A review.Natural killer (NK) cells constitute the subset of lymphocytes that does not need any prior sensitization and that is naturally selectively cytotoxic. NK cells were discovered by Kiessling et al. (1975), while these researchers studied cell-mediated cytotoxicity against tumor cells. The distribution of immune cells (i.e., the ratio of T, B and NK cells) and the number as well as activity of NK cells vary from person to person.These differences provide the basis for the diversity of responsiveness to disease that is observed in a population.Notably, the number of immune cells decreases with stress, and the number and activity of immune cells decreases as they get older. The balance of NK cell activity in the body seems to be the most important for maintaining health.NK cells belong to a group of large granular lymphocytes. They play an important role in the immune system against malignant and infected cells. UnlikeT cells, NK cells act as innate immune cells, showing rapid and selective natural killing of cellular targets with neither any need for major histocompatibility complex class I expression nor any sensitization step.Despite sufficient evidence that NK cells fight tumor cells, pharmaceutical treat ment approaches that target NK cells remain few in number Nevertheless, the possibility of NK cells to be used as therapeutic agent is increasingly supported by recently approved cancer cell-targeting therapies, which proved that it is possible to appropriately regulate NK cell activity.The immune system can be considered as a health barometer in that it is activated when a disease occurs and NK cells are at the heart of this immunomodulation.Considering that NK cells are cells that have immune regulatory functions in the body, this fundamental function resonates echoes many of the bases of Oriental medicine.Here in this review we discuss on the general background of NK cell-based immunotherapy and the activity of clin. research especially focused on Asia.